Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Continue surveillance endoscopy per guidelines
Skip the missed day and continue with the next scheduled injection
Its market placement is characterised by: Novelty: As a relatively new compound, it draws interest from those exploring next-generation enhancement chemistry
Immunostaining revealed mixed cell populations with many undifferentiated hPSCs and mesoderm cells, and DE markers SOX17 and FOXA2 were expressed at lower levels compared to the Activin A-based control (CA)
Monitor responses carefully and adjust based on tolerability and results
US$ 25.11
US$ 25.01
US$ 29.81
US$ 21.20
US$ 20.96
US$ 29.50
US$ 22.06
